Stapokibart shows promise in reducing nasal congestion in seasonal allergy patients, study finds Post author: Post published:February 9, 2024 Post category:uncategorized The efficacy and safety of stapokibart as an in patients with seasonal allergic rhinitis (SAR). You Might Also Like U-M launches interprofessional digital wellness class for sixth graders April 23, 2024 Ultrasound technology shows promise in detecting thoracic surface vibrations March 19, 2024 Binge-eating disorder persists longer than previously thought, study shows May 28, 2024